These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33218271)

  • 1. Evaluation of a Conservative Pharmacist-led U-500R Insulin Management Protocol in the Primary Care Setting.
    Dumont C; Fitzgerald L; Valdez CA
    J Prim Care Community Health; 2020; 11():2150132720973827. PubMed ID: 33218271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc Analysis.
    Hood RC; Chen Y; Sindelar DK; Ly T; Juneja R; Pollom RD; Ilag L; Wysham C
    Endocr Pract; 2021 Aug; 27(8):783-789. PubMed ID: 33515757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of U-500 regular insulin: review and meta-analysis.
    Reutrakul S; Wroblewski K; Brown RL
    J Diabetes Sci Technol; 2012 Mar; 6(2):412-20. PubMed ID: 22538155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Initiating a GLP1 Agonist and/or SGLT2 Inhibitor Therapy on De-Escalation and Discontinuation of Insulin and Diabetes Control When Managed by an Interprofessional Collaborative Team.
    Champion M; Wills Avila G; Garcia AE; Álvarez Delgado FM; Valdez CA
    J Prim Care Community Health; 2024; 15():21501319241231398. PubMed ID: 38353180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
    Salvo MC; Brooks AM
    Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFECT OF TOTAL DAILY DOSE ON EFFICACY, DOSING, AND SAFETY OF 2 DOSE TITRATION REGIMENS OF HUMAN REGULAR U500 INSULIN IN SEVERELY INSULIN-RESISTANT PATIENTS WITH TYPE 2 DIABETES.
    Wysham C; Hood RC; Warren ML; Wang T; Morwick TM; Jackson JA
    Endocr Pract; 2016 Jun; 22(6):653-65. PubMed ID: 26789342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns and outcomes before and after human regular U-500 insulin initiation via KwikPen® among US veterans with type 2 diabetes mellitus.
    Chen J; Borra S; Fan L; Huang A; Patel D; Juneja R
    J Diabetes Complications; 2021 Oct; 35(10):107995. PubMed ID: 34364779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Pharmacist and Physician Collaboration in the Treatment of Type 2 Diabetes Mellitus With Severe Insulin Resistance Using U-500 Insulin.
    Hess R; Brandon S; Johnson F
    South Med J; 2016 Nov; 109(11):690-693. PubMed ID: 27812708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
    Grunberger G; Bhargava A; Ly T; Zisser H; Ilag LL; Malone J; Fan L; Zhang S; Johnson J
    Diabetes Obes Metab; 2020 Mar; 22(3):434-441. PubMed ID: 31865633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Patterns and Outcomes, Before and After Humulin R U-500 Initiation, Among High-Dose Type 2 Diabetes Mellitus Patients in the United States.
    Hood RC; Borra S; Fan L; Pollom RD; Huang A; Chen J
    Endocr Pract; 2021 Aug; 27(8):798-806. PubMed ID: 34089876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach.
    Bergen PM; Kruger DF; Taylor AD; Eid WE; Bhan A; Jackson JA
    Diabetes Educ; 2017 Jun; 43(3):311-323. PubMed ID: 28427304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WITH OR WITHOUT ORAL AGENTS: A RANDOMIZED, TITRATION-TO-TARGET CLINICAL TRIAL.
    Hood RC; Arakaki RF; Wysham C; Li YG; Settles JA; Jackson JA
    Endocr Pract; 2015 Jul; 21(7):782-93. PubMed ID: 25813411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial.
    Kabul S; Hood RC; Duan R; DeLozier AM; Settles J
    Health Qual Life Outcomes; 2016 Sep; 14(1):139. PubMed ID: 27716283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
    Blevins T; Lane W; Rodbard D; Sindelar D; Fan L; Ellinor K; Ilag L; Ly T; Johnson J
    Diabetes Technol Ther; 2021 Jan; 23(1):51-58. PubMed ID: 32631081
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.
    McFarland M; Davis K; Wallace J; Wan J; Cassidy R; Morgan T; Venugopal D
    Pharmacotherapy; 2012 May; 32(5):420-6. PubMed ID: 22488512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance.
    Lane WS; Weinrib SL; Rappaport JM; Przestrzelski T
    Endocr Pract; 2010; 16(5):778-84. PubMed ID: 20350913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U-500 insulin as a component of basal bolus insulin therapy in type 2 diabetes.
    Lowery JB; Donihi AC; Korytkowski MT
    Diabetes Technol Ther; 2012 Jun; 14(6):505-7. PubMed ID: 22364143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Adherence to Insulin Initiation Recommendations at a Suburban Family Medicine Clinic.
    Harris KB; Olin JL
    Am J Ther; 2016; 23(6):e1542-e1546. PubMed ID: 26720168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key.
    Cochran EK; Valentine V; Samaan KH; Corey IB; Jackson JA
    Diabetes Educ; 2014; 40(2):153-65. PubMed ID: 24159006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of U-500 insulin therapy in patients with insulin-resistant type 2 diabetes mellitus.
    Quinn SL; Lansang MC; Mina D
    Pharmacotherapy; 2011 Jul; 31(7):695-702. PubMed ID: 21923457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.